期刊文献+

PTEN蛋白在急性白血病中的表达及其与S期激酶相关蛋白2、血管内皮生长因子的相关性研究 被引量:1

原文传递
导出
摘要 抑癌基因的失活和癌基因的激活与肿瘤的发生、发展密切相关。PTEN基因是迄今为止发现的第一个具有脂质磷酸酶活性的抑癌基因,S期激酶相关蛋白2(SKP2)是新近发现的一种癌基因,血管内皮生长因子(VEGF)是目前研究较为普遍的癌基因,它们的异常表达与人类大多数肿瘤的发生、发展关系密切。目前,已有PTEN基因、SKP2基因及VEGF基因在急性白血病(AL)细胞中表达异常的报道。我们应用细胞免疫化学染色方法检测RTEN蛋白在AL患者骨髓细胞中的表达,分析PTEN与SKP2、VEGF的相关性,探讨PTEN、SKP2及VEGF蛋白水平的异常在AL中的可能作用。
作者 孙慧 王秋红
出处 《中华血液学杂志》 CAS CSCD 北大核心 2007年第1期54-55,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献8

  • 1Leupin N,Cenni B,Novak U,et al.Disparate expression of the PTEN gene:a novel finding in B-cell chronic lymphocytic leukaemia(B-CLL).Br J Haematol,2003,121:97-100.
  • 2王晨,陈芳源,朱建善,许雁萍,韩洁英,欧阳仁荣.急性白血病患者血管内皮生长因子及其受体表达的动态观察[J].中华内科杂志,2004,43(11):845-848. 被引量:4
  • 3Min YH,Cheong JW,Lee MH,et al.Elevated S-phase kinase-associated protein 2 protein expression in acute myelogenous leukemia:its association with constitutive phosphorylation of phosphatase and tensin homologue protein and poor prognosis.Clin Cancer Res,2004,10:5123-5130.
  • 4李英红,陈公琰,徐春林,王彦艳,杨朝阳.PTEN和VEGF在非小细胞肺癌中的表达及相关性研究[J].实用肿瘤学杂志,2005,19(3):163-166. 被引量:8
  • 5Suzuki A,Yamaguchi MT,Ohteki T,et al.T cell specific loss of Pten leads to defects in central and peripheral tolerance.Immunity,2001,14:523-534.
  • 6Fukuda R,Hayashi A,Utsunomiya A,et al.Alteration of phosphatidy-linositol 3-kinase cascade the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL).Proc Natl Acad Sci U S A,2005,102:15213-15218.
  • 7沈权,陈泽,刘旭萍,邢海燕,王敏,王建祥.抑癌基因PTEN mRNA在白血病细胞中的表达及意义[J].中华血液学杂志,2005,26(8):493-496. 被引量:20
  • 8Hamada K,Sasaki T,Koni PA,et al.The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis.Genes Dev,2005,19:2054-2065.

二级参考文献27

  • 1Mangi MH, Newland AC. Angiogenesis and angiogenic mediators in haematological malignancies. Br J Haematol, 2000, 111: 43-51.
  • 2List AF. Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies. Oncologist, 2001, 6 Suppl 5: 24-31.
  • 3Mesters RM, Padro T, Steins M, et al. Angiogenesis in patients with hematologic malignancies. Oncologie, 2001, 24 Suppl 5: 75-80.
  • 4Mesters RM, Padro T, Bieker R, et al. Stable remission after administration of the receptor tyrosine kinase inhibitor SU5416 in a patient with refratory acute myeloid leukemia. Blood, 2001, 98: 241-243.
  • 5Tordjman R, Delaire S, Plouet J, et al. Erythroblasts are a source of angiogenic factors. Blood, 2001, 97: 1968-1974.
  • 6Carmeliet P, Moons L, Luttun A, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med, 2001, 7: 575-583.
  • 7Padro T, Bieker R, Ruiz S, et al. Overexpression of vascular endothelial growth factor and its cellular receptor KDR in the bone marrow of patients with acute myeloid leukemia. Leukemia, 2002, 16: 1302-1310.
  • 8Kroll J, Waltenberger J, Regulation of the endothelial function and angiogenesis by vascular endothelial growth factor-A [J]. Z Kardiol, 2000;89(3):206~218
  • 9Yano T, Tanikawa S, Fujie T, et al. Vascular endothelial growth factor expression and neorascularisation in nonsmall cell lung cancer [J]. Eur J Cancer, 2000;36(5):601~609
  • 10Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in glioblastom a multiforme: relationship to localization and prognosis [J]. Cancer Res, 1999;59(8):1820~1824

共引文献29

同被引文献13

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部